The founding members of pier consortium include:
What is pier?
The Partners in Innovation, Education, and Research Consortium (PIER Consortium™) is a dynamic independent clinical research entity that will advance our understanding of disease and its treatment and meet the needs of our patients, members, and sponsors. Clinical trials have traditionally been offered at academic medical centers and through affiliated hospitals to ensure patients are treated safely and effectively with the best standard of care. PIER will help a broader group of sites participate in trials and thus, offer the opportunity to participate in clinical research to larger numbers of patients, which will also bring new treatments to market faster.
For industry sponsors, the power of PIER is the ability not only to bring clinical trials quickly with high fidelity to members and patients but also to pull deidentified clinical data from members into a shared data warehouse that can be used to increase study efficiency, inform future research, and improve population health. PIER’s mandate for “one contract, one budget, and one IRB” creates a novel competitive mindset that will speed the process for evaluating pioneering treatments and will promote sponsor utilization of PIER within their drug and device development programs.
By eliminating challenges that impede innovation, PIER will provide our researchers and sponsors a centralized service-line approach promoting the development, implementation, and management of clinical research. PIER provides a unique opportunity, not only to founding members but to potential partners by increasing the collective group’s competitive advantage. By using a collaborative model, PIER will realign regional, national, and international relationships.
pier offers solutions
1. Operational Innovation
Trend: Low recruitment, inefficient start-up, reduction in investigators
PIER Role: Consistent business administration, technology infrastructure, training
2. Patient Centricity
Trend: Research is moving from doing things “to” patients, to doing things “with” patients.
PIER Role: Involve patients in advisory boards, study design and communicating results
3. Precision medicine
Trend: Personalized medicine (targeted treatments) resulting in more trials requiring large patient cohorts.
PIER Role: Create large patient pools; mine data efficiently to find subjects.
Trend: Artificial Intelligence; EMRs; Integration of EMR with EDC
PIER Role: Harness new technology to aggregate data from multiple sites; leverage digital health
Trend: Rising Costs and dwindling budgets; loss of expertise in IIS
PIER Role: Use centralized services to free up resources; allows creation of a research fund to foster independent research; collective opportunity to apply for larger grants (e.g. PCORI, CTSAR)